Please note: The first stage of the clinical trial has been completed. We are no longer recruiting new patients and will continue to monitor participating patients in the coming months. A second stage trial may be announced in early 2017. We are grateful for the fantastic support of the participating veterinarians and pet owners who help us immensely in understanding the relations between cancer and the immune system. We are confident this technology will change the way we approach cancer therapy.

 Join A Breakthrough Canine Clinical Trial

Biotempus is excited to announce the launch of our clinical trial for Canine cancer patients.
The trial involves mapping the immune cycle of dogs at participating veterinary clinics around Australia.

Owners of dogs with advanced cancer are invited to fill out the short eligibility form to see if they can join our study. Qualified participants will undergo serial blood testing every second day over 2-4 weeks prior to treatment. Blood results will be analyzed by our patented algorithm and a treatment date will be provided to the veterinarian. Treatment consist of a single oral dose of chemotherapy using Cyclophosphamide or Chlorambucil.

I am a…